Zenas BioPharma, Inc.

SEC 4 · Filed

0001104659-26-075249Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 15, 2026

Grant, award or other acquisition by Fox Jennifer A.

Security
Stock Option (Right to Buy)
Code
A
Shares
125,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-15",
  "direction": "A",
  "exercise_price": "18.71",
  "expiration": "2036-06-15",
  "footnotes": {
    "F2": "The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service."
  },
  "owners": [
    {
      "cik": "0001841557",
      "name": "Fox Jennifer A.",
      "roles": [
        "officer"
      ],
      "title": "See Remarks"
    }
  ],
  "ownership": "D",
  "post_shares": "125000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "125000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "125000"
}
Insider transactionsEvent date Feb 5, 2026

Grant, award or other acquisition by Fox Jennifer A.

Security
Common Stock
Code
A
Shares
1,592
Price per share
13.35
Structured facts
{
  "code": "A",
  "date": "2026-02-05",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Common Stock acquired under Zenas BioPharma, Inc.\u0027s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c)."
  },
  "owners": [
    {
      "cik": "0001841557",
      "name": "Fox Jennifer A.",
      "roles": [
        "officer"
      ],
      "title": "See Remarks"
    }
  ],
  "ownership": "D",
  "post_shares": "1592",
  "price": "13.35",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "1592",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}